Can nasal and sinus inflammation activate trigeminal pain pathways and worsen sleep breathing?

Nasal/sinus inflammation can plausibly link congestion, facial pain, and sleep-breathing difficulties, but the strength of evidence differs across this pathway. The best-supported elements are trigeminal activation and its relevance to headache; effects on overnight airflow and apnea severity are more variable.

Trigeminal and headache mechanisms

• Experimental paranasal inflammation or irritant stimulation activates spinal trigeminal neurons and the trigeminal nucleus caudalis, with dural neurogenic inflammation and pain behaviors.
• TRPV1/TRPA1 activation in sinonasal tissue can drive a CGRP-dependent meningeal vascular response; CGRP antagonism blocks this response in experimental models. Allergic rhinosinusitis has also been associated with elevated salivary CGRP that falls with symptom-relieving treatment.
• Trigeminal–autonomic and CGRP signaling are established contributors to migraine burden. However, congestion, rhinorrhea, facial pressure, and tearing often occur because of migraine-related trigeminal activation; they do not establish sinus disease as the headache cause.

Nasal airflow and sleep-disordered breathing

• Mucosal/turbinate edema, recumbent venous congestion, and sleep-related nasal-cycle changes make inflammation-related worsening of nighttime nasal resistance biologically credible.
• Reduced nasal patency may aggravate sleep-disordered breathing in selected people, but nasal treatment has mixed, generally modest effects on apnea–hypopnea index (AHI). In one small crossover trial of rhinitis, fluticasone reduced median AHI from 20 to 12 events/hour, without improved oxygenation, sleep quality, or sleepiness; another placebo-controlled trial found no overall AHI benefit.
• The clearest practical benefit is improved PAP treatment: nasal surgery reduced therapeutic CPAP pressure by a pooled 2.66 cmH₂O and increased short-term objective use from 3.0 to 5.5 hours/night.

Bottom line

• Sinonasal inflammation can engage trigeminal pain biology and may worsen nocturnal nasal obstruction, potentially amplifying headaches and sleep-disordered breathing. Clinically, address demonstrable nasal disease and PAP-limiting obstruction, but do not assume “sinus” symptoms explain recurrent headache or that nasal treatment alone will reliably treat obstructive sleep apnea.